专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20130029979A1 FUSED BICYCLIC COMPOUND 有权
标题翻译：熔融双相化合物
公开(公告)号：US20130029979A1
公开(公告)日：2013-01-31
申请号：US13561662
申请日：2012-07-30
申请人： Yoichi TAKAHASHI , Nobumasa Awai , Hidenori Akatsuka , Takayuki Kawaguchi , Toru Iljima
发明人： Yoichi TAKAHASHI , Nobumasa Awai , Hidenori Akatsuka , Takayuki Kawaguchi , Toru Iljima
IPC分类号： C07D265/16 , C07D311/04 , A61K31/352 , C07D413/04 , A61P9/06 , C07D405/04 , A61K31/4433 , A61P9/12 , A61P9/04 , A61K31/536 , C07D307/94
CPC分类号： C07D265/16 , C07D311/20 , C07D311/58 , C07D311/96 , C07D405/14 , C07D413/04
摘要： Fused bicyclic compound having an affinity to mineral corticoid receptor (MR), of formula [I]: wherein ring A is benzene having a substituent R1, fused to an adjacent 6-membered heterocyclic ring and further optionally having a substituent(s) other than R1, R1 is alkylsulfonylamino, etc., R2 and R3 are (a) the same of different and are hydrogen, alkyl, or optionally substituted aryl, or (b) combined with each other to form an oxo group or (c) combined with each other at its terminal together with the adjacent carbon atom to form cycloalkyl, X is ═N—, ═C(R4)— or —CH(R4)—, R4 is (a) hydrogen, (b) cyano, (c) halogen, (d) alkyl, (e) alkenyl, (f) cycloalkyl, (g) alkanoyl, (h) carbamoyl, or (i) cycloalkenyl, Ar is an optionally substituted aromatic cyclic group and a dotted line means presence or absence of a double bond, or a pharmaceutically acceptable salt thereof, useful e.g. as an antihypertensive agent.
摘要翻译：具有式[I]的矿物质类皮质激素受体（MR）的亲和性的稠合双环化合物：其中环A是具有取代基R 1的苯，与相邻的6元杂环稠合，并且进一步任选具有除 R 1，R 1是烷基磺酰基氨基等，R 2和R 3是（a）不同的并且是氢，烷基或任选取代的芳基，或（b）彼此结合形成氧代基或（c）与 X是= N - ， - C（R4） - 或-CH（R4） - ，R4是（a）氢，（b）氰基，（c）卤素，（d）烷基，（e）烯基，（f）环烷基，（g）烷酰基，（h）氨基甲酰基或（i）环烯基，Ar是任选取代的芳族环状基团，虚线表示存在或不存在双键或其药学上可接受的盐，例如，作为抗高血压药。

2. 发明授权

US08410166B2 Fused bicyclic compound 有权
标题翻译：稠合双环化合物
公开(公告)号：US08410166B2
公开(公告)日：2013-04-02
申请号：US13561662
申请日：2012-07-30
申请人： Yoichi Takahashi , Nobumasa Awai , Hidenori Akatsuka , Takayuki Kawaguchi , Toru Iljima
发明人： Yoichi Takahashi , Nobumasa Awai , Hidenori Akatsuka , Takayuki Kawaguchi , Toru Iljima
IPC分类号： C07D265/00
CPC分类号： C07D265/16 , C07D311/20 , C07D311/58 , C07D311/96 , C07D405/14 , C07D413/04
摘要： Fused bicyclic compound having an affinity to mineral corticoid receptor (MR), of formula [I]: wherein ring A is benzene having a substituent R1, fused to an adjacent 6-membered heterocyclic ring and further optionally having a substituent(s) other than R1, R1 is alkylsulfonylamino, etc., R2 and R3 are (a) the same of different and are hydrogen, alkyl, or optionally substituted aryl, or (b) combined with each other to form an oxo group or (c) combined with each other at its terminal together with the adjacent carbon atom to form cycloalkyl, X is ═N—, ═C(R4)— or —CH(R4)—, R4 is (a) hydrogen, (b) cyano, (c) halogen, (d) alkyl, (e) alkenyl, (f) cycloalkyl, (g) alkanoyl, (h) carbamoyl, or (i) cycloalkenyl, Ar is an optionally substituted aromatic cyclic group and a dotted line means presence or absence of a double bond, or a pharmaceutically acceptable salt thereof, useful e.g. as an antihypertensive agent.
摘要翻译：具有式[I]的矿物质类皮质激素受体（MR）的亲和性的稠合双环化合物：其中环A是具有取代基R 1的苯，与相邻的6元杂环稠合，并且进一步任选具有除 R 1，R 1是烷基磺酰基氨基等，R 2和R 3是（a）不同的并且是氢，烷基或任选取代的芳基，或（b）彼此结合形成氧代基或（c）与 X是= N - ， - C（R4） - 或-CH（R4） - ，R4是（a）氢，（b）氰基，（c）卤素，（d）烷基，（e）烯基，（f）环烷基，（g）烷酰基，（h）氨基甲酰基或（i）环烯基，Ar是任选取代的芳族环状基团，虚线表示存在或不存在双键或其药学上可接受的盐，例如，作为抗高血压药。

3. 发明申请

US20100204218A1 FUSED BICYCLIC COMPOUND 有权
标题翻译：熔融双相化合物
公开(公告)号：US20100204218A1
公开(公告)日：2010-08-12
申请号：US12671479
申请日：2008-07-21
申请人： Yoichi Takahashi , Nobumasa Awai , Hidenori Akatsuka , Takayuki Kawaguchi , Toru Iijima
发明人： Yoichi Takahashi , Nobumasa Awai , Hidenori Akatsuka , Takayuki Kawaguchi , Toru Iijima
IPC分类号： A61K31/536 , C07D265/14 , C07D307/94 , A61K31/352 , A61P9/12 , A61P9/06 , A61P9/00
CPC分类号： C07D265/16 , C07D311/20 , C07D311/58 , C07D311/96 , C07D405/14 , C07D413/04
摘要： The present invention provides a novel fused bicyclic compound having an affinity to a receptor of mineral corticoid (MR), shown by the formula [I]: wherein the ring A is a benzene ring having a substituent R1, fused to an adjacent 6-membered heterocyclic ring and further optionally having a substituent(s) other than R1, R1 is an alkylsulfonylamino group etc., R2 and R3 are (a) the same of different and a hydrogen atom, an alkyl group or a substituted or unsubstituted aryl group, (b) combined each other to form an oxo group or (c) combined each other at its terminal together with the adjacent carbon atom to form a cycloalkyl group, X is a group of ═N—, ═C(R4)— or —CH(R4)—, R4 is (a) a hydrogen atom, (b) a cyano group, (c) a halogen atom, (d) an alkyl group, (e) an alkenyl group, (f) a cycloalkyl group (g) an alkanoyl group, (h) a carbamoyl group or (i) a cycloalkenyl group, Ar is an optionally substituted aromatic cyclic group and a dotted line means presence or absence of a double bond, or a pharmaceutically acceptable salt thereof, which is useful as an antihypertensive agent etc.
摘要翻译：本发明提供了对式[I]所示的对矿物质类皮质激素（MR）的受体具有亲和性的新的稠合双环化合物：其中环A是具有取代基R 1的苯环，与相邻的6元杂环，并且还可任选地具有除R1以外的取代基，R 1是烷基磺酰基氨基等，R 2和R 3是（a）不同的，和氢原子，烷基或取代或未取代的芳基，（b）彼此组合以形成氧代基团，或（c）在其末端与相邻的碳原子一起相互结合形成环烷基，X是一个= N - ， - C（R 4） - 或 - CH（R4） - ，R4是（a）氢原子，（b）氰基，（c）卤原子，（d）烷基，（e）烯基，（f）环烷基 g）烷酰基，（h）氨基甲酰基或（i）环烯基，Ar是任选取代的芳环基，虚线表示存在或不存在双键或其药学上可接受的盐，其可用作抗高血压剂等。

4. 发明申请

US20100240644A1 MORPHOLINE DERIVATIVE 有权
标题翻译：吗啉衍生物
公开(公告)号：US20100240644A1
公开(公告)日：2010-09-23
申请号：US12664637
申请日：2008-06-16
申请人： Hidenori Akatsuka , Hiroshi Sugama , Nobumasa Awai , Takayuki Kawaguchi , Yoichi Takahashi , Toru Iijima , Jingkang Shen , Guangxin Xia , Jianshu Xie
发明人： Hidenori Akatsuka , Hiroshi Sugama , Nobumasa Awai , Takayuki Kawaguchi , Yoichi Takahashi , Toru Iijima , Jingkang Shen , Guangxin Xia , Jianshu Xie
IPC分类号： A61K31/538 , C07D265/30 , A61K31/5375 , C07D265/36 , C07D413/12 , A61K31/5377 , C07D409/12 , A61K31/5355 , A61P9/12
CPC分类号： C07D265/30 , C07D209/08 , C07D209/14 , C07D209/30 , C07D209/34 , C07D209/42 , C07D231/56 , C07D265/36 , C07D403/04 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/04
摘要： The present invention provides a morpholine derivative of the formula [I]; wherein R1 is a substituted alkyl group, an optionally substituted aryl group, an optionally substituted heterocyclo group, a cycloalkyl group or an alkyl group; R2 is a substituted alkyl group, an optionally substituted aryl group, an optionally substituted heterocyclo group, an optionally substituted alkylcarbonyl group, an optionally substituted arylcarbonyl group, an optionally substituted heterocyclo-substituted carbonyl group or a cycloalkylcarbonyl group; T is a methylene group or a carbonyl group; R3, R4, R5 and R6 are the same or different and a hydrogen atom, an optionally substituted carbamoyl group or an optionally substituted alkyl group; or pharmaceutically acceptable salts thereof. These compounds are useful as a renin inhibitor.
摘要翻译：本发明提供式[I]的吗啉衍生物。其中R1是取代的烷基，任选取代的芳基，任选取代的杂环基，环烷基或烷基; R 2是取代的烷基，任选取代的芳基，任选取代的杂环基，任选取代的烷基羰基，任选取代的芳基羰基，任选取代的杂环取代的羰基或环烷基羰基; T是亚甲基或羰基; R3，R4，R5和R6相同或不同，氢原子，任选取代的氨基甲酰基或任选取代的烷基; 或其药学上可接受的盐。这些化合物可用作肾素抑制剂。

5. 发明授权

US08975252B2 Morpholine derivative 有权
标题翻译：吗啉衍生物
公开(公告)号：US08975252B2
公开(公告)日：2015-03-10
申请号：US12664637
申请日：2008-06-16
申请人： Hidenori Akatsuka , Hiroshi Sugama , Nobumasa Awai , Takayuki Kawaguchi , Yoichi Takahashi , Toru Iijima , Jingkang Shen , Guangxin Xia , Jianshu Xie
发明人： Hidenori Akatsuka , Hiroshi Sugama , Nobumasa Awai , Takayuki Kawaguchi , Yoichi Takahashi , Toru Iijima , Jingkang Shen , Guangxin Xia , Jianshu Xie
IPC分类号： A61K31/535 , C07D265/30 , C07D209/08 , C07D209/14 , C07D209/30 , C07D209/34 , C07D209/42 , C07D231/56 , C07D265/36 , C07D403/04 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/04
CPC分类号： C07D265/30 , C07D209/08 , C07D209/14 , C07D209/30 , C07D209/34 , C07D209/42 , C07D231/56 , C07D265/36 , C07D403/04 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/14 , C07D471/04
摘要： The present invention provides a morpholine derivative of the formula [I]; wherein R1 is a substituted alkyl group, an optionally substituted aryl group, an optionally substituted heterocyclo group, a cycloalkyl group or an alkyl group; R2 is a substituted alkyl group, an optionally substituted aryl group, an optionally substituted heterocyclo group, an optionally substituted alkylcarbonyl group, an optionally substituted arylcarbonyl group, an optionally substituted heterocyclo-substituted carbonyl group or a cycloalkylcarbonyl group; T is a methylene group or a carbonyl group; R3, R4, R5 and R6 are the same or different and a hydrogen atom, an optionally substituted carbamoyl group or an optionally substituted alkyl group; or pharmaceutically acceptable salts thereof. These compounds are useful as a renin inhibitor.
摘要翻译：本发明提供式[I]的吗啉衍生物。其中R1是取代的烷基，任选取代的芳基，任选取代的杂环基，环烷基或烷基; R 2是取代的烷基，任选取代的芳基，任选取代的杂环基，任选取代的烷基羰基，任选取代的芳基羰基，任选取代的杂环取代的羰基或环烷基羰基; T是亚甲基或羰基; R3，R4，R5和R6相同或不同，氢原子，任选取代的氨基甲酰基或任选取代的烷基; 或其药学上可接受的盐。这些化合物可用作肾素抑制剂。

6. 发明授权

US08258131B2 Fused bicyclic compound 有权
标题翻译：稠合双环化合物
公开(公告)号：US08258131B2
公开(公告)日：2012-09-04
申请号：US12671479
申请日：2008-07-21
申请人： Yoichi Takahashi , Nobumasa Awai , Hidenori Akatsuka , Takayuki Kawaguchi , Toru Iijima
发明人： Yoichi Takahashi , Nobumasa Awai , Hidenori Akatsuka , Takayuki Kawaguchi , Toru Iijima
IPC分类号： C07D265/16 , A61K31/352 , A61K31/353
CPC分类号： C07D265/16 , C07D311/20 , C07D311/58 , C07D311/96 , C07D405/14 , C07D413/04
摘要： The present invention provides a novel fused bicyclic compound having an affinity to a receptor of mineral corticoid (MR), shown by the formula [I]: wherein the ring A is a benzene ring having a substituent R1, fused to an adjacent 6-membered heterocyclic ring and further optionally having a substituent(s) other than R1, R1 is an alkylsulfonylamino group etc., R2 and R3 are (a) the same of different and a hydrogen atom, an alkyl group or a substituted or unsubstituted aryl group, (b) combined each other to form an oxo group or (c) combined each other at its terminal together with the adjacent carbon atom to form a cycloalkyl group, X is a group of ═N—, ═C(R4)— or —CH(R4)—, R4 is (a) a hydrogen atom, (b) a cyano group, (c) a halogen atom, (d) an alkyl group, (e) an alkenyl group, (f) a cycloalkyl group (g) an alkanoyl group, (h) a carbamoyl group or (i) a cycloalkenyl group, Ar is an optionally substituted aromatic cyclic group and a dotted line means presence or absence of a double bond, or a pharmaceutically acceptable salt thereof, which is useful as an antihypertensive agent etc.
摘要翻译：本发明提供了对式[I]所示的对矿物质类皮质激素（MR）的受体具有亲和性的新的稠合双环化合物：其中环A是具有取代基R 1的苯环，与相邻的6元杂环，并且还可任选地具有除R1以外的取代基，R 1是烷基磺酰基氨基等，R 2和R 3是（a）不同的，和氢原子，烷基或取代或未取代的芳基，（b）彼此组合以形成氧代基团，或（c）在其末端与相邻的碳原子一起相互结合形成环烷基，X是一个= N - ， - C（R 4） - 或 - CH（R4） - ，R4是（a）氢原子，（b）氰基，（c）卤原子，（d）烷基，（e）烯基，（f）环烷基 g）烷酰基，（h）氨基甲酰基或（i）环烯基，Ar是任选取代的芳环基，虚线表示存在或不存在双键或其药学上可接受的盐，其可用作抗高血压剂等。

7. 发明申请

US20140005393A1 SULFONAMIDE COMPOUNDS HAVING TRPM8 ANTAGONISTIC ACTIVITY 有权
标题翻译：具有TRPM8拮抗活性的磺酰胺化合物
公开(公告)号：US20140005393A1
公开(公告)日：2014-01-02
申请号：US14004911
申请日：2012-03-15
申请人： Yasuyuki Tsuzuki , Daisuke Sawamoto , Toshiaki Sakamoto , Taku Kato , Yasuki Miwa , Nobumasa Awai
发明人： Yasuyuki Tsuzuki , Daisuke Sawamoto , Toshiaki Sakamoto , Taku Kato , Yasuki Miwa , Nobumasa Awai
IPC分类号： C07D487/04 , C07D405/12 , C07D401/12 , C07D217/22 , C07D409/12
CPC分类号： C07D413/12 , C07D215/38 , C07D217/22 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D487/04
摘要： Sulfonamide compounds having TRPM8 antagonistic activity are provided. A sulfonamide compound of formula (I) or a pharmaceutically acceptable salt thereof, or a prodrug thereof: (I) wherein Ring A is bicyclic aromatic heterocycle comprised of (a) pyridine is condensed with benzene; or (b) pyridine is condensed with monocyclic aromatic heterocycle, and Ring A binds to a sulfonylamino moiety on a carbon atom adjacent to a nitrogen atom of the pyridine ring constituting Ring A, Ring B is (a) monocyclic or bicyclic aromatic hydrocarbon; (b) monocyclic or bicyclic alicyclic hydrocarbon; (c) monocyclic or bicyclic aromatic heterocycle; or (d) monocyclic or bicyclic non-aromatic heterocycle, Ring C is (a) benzene; or (b) monocyclic aromatic heterocycle, and other symbols are the same as defined in the specification.
摘要翻译：提供了具有TRPM8拮抗活性的磺酰胺化合物。式（I）的磺酰胺化合物或其药学上可接受的盐或其前药：（I）其中环A是由（a）吡啶组成的双环芳族杂环与苯稠合; 或（b）吡啶与单环芳族杂环稠合，环A与构成环A的吡啶环的氮原子相邻的碳原子上的磺酰基氨基部分结合，环B为（a）单环或双环芳烃; （b）单环或双环脂环烃; （c）单环或双环芳族杂环; 或（d）单环或双环非芳族杂环，环C为（a）苯; 或（b）单环芳族杂环，以及其他符号与说明书中所定义的相同。

8. 发明授权

US09540360B2 Sulfonamide compounds having TRPM8 antagonistic activity 有权
标题翻译：具有TRPM8拮抗活性的磺酰胺化合物
公开(公告)号：US09540360B2
公开(公告)日：2017-01-10
申请号：US14620360
申请日：2015-02-12
申请人： Yasuyuki Tsuzuki , Daisuke Sawamoto , Toshiaki Sakamoto , Taku Kato , Yasuki Niwa , Nobumasa Awai
发明人： Yasuyuki Tsuzuki , Daisuke Sawamoto , Toshiaki Sakamoto , Taku Kato , Yasuki Niwa , Nobumasa Awai
IPC分类号： A61K31/4709 , A61K31/4725 , A61K31/472 , C07D413/12 , C07D217/22 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D215/38
CPC分类号： C07D413/12 , C07D215/38 , C07D217/22 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D487/04
摘要： Sulfonamide compounds having TRPM8 antagonistic activity are provided. A sulfonamide compound of formula (I) or a pharmaceutically acceptable salt thereof, or a prodrug thereof: wherein Ring A is bicyclic aromatic heterocycle comprised of (a) pyridine is condensed with benzene; or (b) pyridine is condensed with monocyclic aromatic heterocycle, and Ring A binds to a sulfonylamino moiety on a carbon atom adjacent to a nitrogen atom of the pyridine ring constituting Ring A, Ring B is (a) monocyclic or bicyclic aromatic hydrocarbon; (b) monocyclic or bicyclic alicyclic hydrocarbon; (c) monocyclic or bicyclic aromatic heterocycle; or (d) monocyclic or bicyclic non-aromatic heterocycle, Ring C is (a) benzene; or (b) monocyclic aromatic heterocycle, and other symbols are the same as defined in the specification.
摘要翻译：提供了具有TRPM8拮抗活性的磺酰胺化合物。式（I）的磺酰胺化合物或其药学上可接受的盐或其前药：其中环A是由（a）吡啶组成的双环芳族杂环与苯稠合; 或（b）吡啶与单环芳族杂环稠合，环A与构成环A的吡啶环的氮原子相邻的碳原子上的磺酰基氨基部分结合，环B为（a）单环或双环芳烃; （b）单环或双环脂环烃; （c）单环或双环芳族杂环; 或（d）单环或双环非芳族杂环，环C为（a）苯; 或（b）单环芳族杂环，以及其他符号与说明书中所定义的相同。

9. 发明申请

US20070060629A1 Large conductance calcium-activated k channel opener 审中-公开
标题翻译：大电导钙激活k通道开放剂
公开(公告)号：US20070060629A1
公开(公告)日：2007-03-15
申请号：US10574529
申请日：2004-10-15
申请人： Yasuhiro Imanishi , Nobumasa Awai , Miki Hirai , Toshihiro Hosaka , Rikako Kono
发明人： Yasuhiro Imanishi , Nobumasa Awai , Miki Hirai , Toshihiro Hosaka , Rikako Kono
IPC分类号： C07D231/12 , C07D261/06 , A61K31/42 , A61K31/415
CPC分类号： C07D231/12 , A61K31/415 , A61K31/42 , C07D231/38 , C07D261/08 , C07D401/04 , C07D403/04 , C07D403/12 , C07D405/04 , C07D409/04 , C07D413/04 , C07D413/12 , C07D413/14 , C07D471/04 , C07D495/04 , C07D513/04
摘要： The present invention provides a large conductance calcium-activated K channel opener comprising a compound of the formula (I): wherein R1 and R3 are each sulfonamide, carbamoyl, acyl, amino, and the like, m and n are each 0 to 2, R2 and R4 are each cyano, nitro, hydroxyl, an alkoxy, a halogen, or an alkyl, Ring A is benzene or a heterocyclic ring, Ring B is benzene, a heterocyclic ring, a cycloalkane etc, and Ring Q is pyrazole or isoxazole, or a pharmaceutically acceptable salt thereof as an active ingredient.
摘要翻译：本发明提供了包含式（I）化合物的大电导钙激活K通道开放剂：其中R 1和R 3各自为磺酰胺，氨基甲酰基，酰基，氨基等，m和n各自为0至2，R 2和R 4各自为氰基，硝基，羟基，烷氧基，卤素或烷基，环A是苯或杂环，环B是苯，杂环，环烷烃等，环Q是吡唑或异恶唑或其药学上可接受的盐作为活性成分。

10. 发明授权

US08987445B2 Sulfonamide compounds having TRPM8 antagonistic activity 有权
标题翻译：具有TRPM8拮抗活性的磺酰胺化合物
公开(公告)号：US08987445B2
公开(公告)日：2015-03-24
申请号：US14004911
申请日：2012-03-15
申请人： Yasuyuki Tsuzuki , Daisuke Sawamoto , Toshiaki Sakamoto , Taku Kato , Yasuki Niwa , Nobumasa Awai
发明人： Yasuyuki Tsuzuki , Daisuke Sawamoto , Toshiaki Sakamoto , Taku Kato , Yasuki Niwa , Nobumasa Awai
IPC分类号： C07D487/04 , C07D405/12 , C07D401/12 , C07D409/12 , C07D471/04 , C07D417/12 , C07D413/12 , C07D217/22
CPC分类号： C07D413/12 , C07D215/38 , C07D217/22 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D487/04
摘要： Sulfonamide compounds having TRPM8 antagonistic activity are provided. A sulfonamide compound of formula (I) or a pharmaceutically acceptable salt thereof, or a prodrug thereof: (I) wherein Ring A is bicyclic aromatic heterocycle comprised of (a) pyridine is condensed with benzene; or (b) pyridine is condensed with monocyclic aromatic heterocycle, and Ring A binds to a sulfonylamino moiety on a carbon atom adjacent to a nitrogen atom of the pyridine ring constituting Ring A, Ring B is (a) monocyclic or bicyclic aromatic hydrocarbon; (b) monocyclic or bicyclic alicyclic hydrocarbon; (c) monocyclic or bicyclic aromatic heterocycle; or (d) monocyclic or bicyclic non-aromatic heterocycle, Ring C is (a) benzene; or (b) monocyclic aromatic heterocycle, and other symbols are the same as defined in the specification.
摘要翻译：提供了具有TRPM8拮抗活性的磺酰胺化合物。式（I）的磺酰胺化合物或其药学上可接受的盐或其前药：（I）其中环A是由（a）吡啶组成的双环芳族杂环与苯稠合; 或（b）吡啶与单环芳族杂环稠合，环A与构成环A的吡啶环的氮原子相邻的碳原子上的磺酰基氨基部分结合，环B为（a）单环或双环芳烃; （b）单环或双环脂环烃; （c）单环或双环芳族杂环; 或（d）单环或双环非芳族杂环，环C为（a）苯; 或（b）单环芳族杂环，以及其他符号与说明书中所定义的相同。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式